"There’s no longer a blanket statement that everybody who’s at increased risk for heart disease, even though they never had a heart attack, should be on aspirin. We need to be smarter at matching primary prevention to the people who will benefit the most and have the least risk of harms."

Dr. Chien-Wen Tseng, a member of U.S. Preventive Services Task Force that is studying the effects of a daily regimen of low-dose aspirin, commenting to The New York Times this week for its report, “Aspirin Use to Prevent 1st Heart Attack or Stroke Should Be Curtailed, U.S. Panel Says.” Tseng is the research director of family medicine and community health at the University of Hawaii.